These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 476461)

  • 21. Clostridium difficile-associated colitis after neomycin treated with metronidazole.
    Bolton RP
    Br Med J; 1979 Dec; 2(6203):1479-80. PubMed ID: 526821
    [No Abstract]   [Full Text] [Related]  

  • 22. Commentary on "High frequency of nonadherence to Clostridium difficile treatment guidelines".
    Froom P
    South Med J; 2014 Sep; 107(9):600-1. PubMed ID: 25188628
    [No Abstract]   [Full Text] [Related]  

  • 23. Cefotaxime-associated diarrhea and Clostridium difficile.
    Funada H; Ishizaki T; Kuroda T; Hattori K; Nakamura S
    Jpn J Antibiot; 1984 Apr; 37(4):555-7. PubMed ID: 6088823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal Microbiota Transplantation in Recurrent NAP1/B1/027 Clostridium Difficile Infection (CDI) Resistant to Vancomycin and Metronidazole in a Patient with Ulcerative Colitis (UC): A Case Report.
    Preda CM; Meianu C; Sandra I; Becheanu G; Dumbrava M; Manuc M; Diculescu M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):563-7. PubMed ID: 30044904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin therapy for severe Clostridium difficile-associated diarrhea.
    Huggan PJ; Murdoch DR
    Clin Infect Dis; 2007 Dec; 45(12):1647-8; author reply 1649-51. PubMed ID: 18190330
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical inquiries. What are effective therapies for Clostridium difficile-associated diarrhea?
    Ohl ME; Stevermer JJ; Meadows S; Tribuna J; Chek K
    J Fam Pract; 2005 Feb; 54(2):176-8. PubMed ID: 15689297
    [No Abstract]   [Full Text] [Related]  

  • 27. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials.
    Johnson S; Louie TJ; Gerding DN; Cornely OA; Chasan-Taber S; Fitts D; Gelone SP; Broom C; Davidson DM;
    Clin Infect Dis; 2014 Aug; 59(3):345-54. PubMed ID: 24799326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy.
    Walters BA; Roberts R; Stafford R; Seneviratne E
    Gut; 1983 Mar; 24(3):206-12. PubMed ID: 6826104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managing C. difficile-associated diarrhea.
    Bailey EM
    Am J Health Syst Pharm; 1998 Jul; 55(13):1365. PubMed ID: 9659963
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of Clostridium difficile colitis and diarrhea with vancomycin.
    Silva J; Batts DH; Fekety R; Plouffe JF; Rifkin GD; Baird I
    Am J Med; 1981 Nov; 71(5):815-22. PubMed ID: 7304654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Best strategies in recurrent or persistent Clostridium difficile infection.
    Cocanour CS
    Surg Infect (Larchmt); 2011 Jun; 12(3):235-9. PubMed ID: 21767157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clostridium difficile-associated disease treatment response depends on definition of cure.
    Lawrence SJ; Dubberke ER; Johnson S; Gerding DN
    Clin Infect Dis; 2007 Dec; 45(12):1648; author reply 1649-51. PubMed ID: 18190331
    [No Abstract]   [Full Text] [Related]  

  • 33. Therapy for Clostridium difficile infection - any news beyond Metronidazole and Vancomycin?
    Manthey CF; Eckmann L; Fuhrmann V
    Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1239-1250. PubMed ID: 28766951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium difficile colitis.
    Trnka YM; Lamont JT
    Adv Intern Med; 1984; 29():85-107. PubMed ID: 6369936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison.
    Cornely OA; Nathwani D; Ivanescu C; Odufowora-Sita O; Retsa P; Odeyemi IA
    J Antimicrob Chemother; 2014 Nov; 69(11):2892-900. PubMed ID: 25074856
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Individualized treatment strategies for Clostridium difficile infections].
    Solbach P; Dersch P; Bachmann O
    Internist (Berl); 2017 Jul; 58(7):675-681. PubMed ID: 28589214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clostridium difficile infection in older adults: a review and update on its management.
    Kee VR
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of treatment patterns and patient outcomes before vs after implementation of a severity-based Clostridium difficile infection treatment policy.
    Jardin CG; Palmer HR; Shah DN; Le F; Beyda ND; Jiang Z; Garey KW
    J Hosp Infect; 2013 Sep; 85(1):28-32. PubMed ID: 23834988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High frequency of nonadherence to Clostridium difficile treatment guidelines.
    McEllistrem MC; McGraw M; Sahud AG; Chan-Tompkins NH; Goswami R; Bhanot N
    South Med J; 2014 Sep; 107(9):597-9. PubMed ID: 25188627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous metronidazole for fulminant Clostridioides difficile infection.
    Pipitone G; Granata G; Sartelli M; Gizzi A; Imburgia C; Cascio A; Iaria C
    Clin Microbiol Infect; 2023 May; 29(5):656-657. PubMed ID: 36739974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.